Long‐term use of romiplostim in the treatment of refractory immune‐mediated thrombocytopenia in a dog

Documents similaires

• Associative and self‐limiting immune‐mediated haemolytic anaemia in a dog with bicavitary sepsis
  par: Clara Mattavelli, et autres
  Publié: (2024)
• Inducible haemorrhage (epistaxis) secondary to lomustine administration without thrombocytopenia in a dog
  par: Andrew Schlueter, et autres
  Publié: (2025)
• Use of omega‐3 fatty acid supplementation for treatment of refractory ventricular arrhythmias in two dogs
  par: Rebecca Saunders
  Publié: (2025)
• Primary immune‐mediated neutropenia as part of a relapse of previously diagnosed Evans syndrome in a dog
  par: Victoria Carter, et autres
  Publié: (2025)
• Improved bilirubin reduction with therapeutic plasma exchange and haemoperfusion in a dog with immune‐mediated haemolytic anaemia
  par: Natasha S. Yeh, et autres
  Publié: (2026)